Investors Met With Slowing Returns on Capital At Jointown Pharmaceutical Group (SHSE:600998)
Feb 15
Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Distributors Industry Analysis
UpdatedFeb 16, 2025
DataAggregated Company Financials
Companies23
- 7D1.1%
- 3M-4.0%
- 1Y4.4%
- YTDn/a
Over the last 7 days, the Healthcare Distributors industry has risen 1.8%, driven by gains from China Reform Health Management and Services Group of 10%. This means that the industry has gained 3.2% over the past year. Earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Chinese Healthcare Distributors Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 16 Feb 2025 | CN¥309.5b | CN¥910.6b | CN¥16.5b | 18.5x | 18.8x | 0.3x |
| Tue, 14 Jan 2025 | CN¥291.9b | CN¥910.3b | CN¥16.5b | 17.4x | 17.7x | 0.3x |
| Thu, 12 Dec 2024 | CN¥335.8b | CN¥910.6b | CN¥16.5b | 20.1x | 20.4x | 0.4x |
| Sat, 09 Nov 2024 | CN¥326.0b | CN¥910.6b | CN¥16.5b | 18.9x | 19.8x | 0.4x |
| Mon, 07 Oct 2024 | CN¥324.6b | CN¥900.2b | CN¥16.4b | 19.4x | 19.8x | 0.4x |
| Wed, 04 Sep 2024 | CN¥268.8b | CN¥900.2b | CN¥16.4b | 16.7x | 16.4x | 0.3x |
| Fri, 02 Aug 2024 | CN¥279.9b | CN¥904.3b | CN¥16.5b | 15.3x | 17x | 0.3x |
| Sun, 30 Jun 2024 | CN¥276.8b | CN¥904.3b | CN¥16.5b | 15.3x | 16.8x | 0.3x |
| Tue, 28 May 2024 | CN¥313.4b | CN¥904.3b | CN¥16.5b | 17.4x | 19x | 0.3x |
| Thu, 25 Apr 2024 | CN¥305.8b | CN¥904.4b | CN¥14.9b | 16.1x | 20.5x | 0.3x |
| Sat, 23 Mar 2024 | CN¥304.8b | CN¥897.3b | CN¥15.7b | 13.9x | 19.4x | 0.3x |
| Mon, 19 Feb 2024 | CN¥297.1b | CN¥894.8b | CN¥15.5b | 14.2x | 19.2x | 0.3x |
| Wed, 17 Jan 2024 | CN¥309.3b | CN¥893.5b | CN¥15.5b | 14.5x | 20x | 0.3x |
| Fri, 15 Dec 2023 | CN¥333.8b | CN¥893.5b | CN¥15.5b | 15.7x | 21.6x | 0.4x |
| Sun, 12 Nov 2023 | CN¥338.5b | CN¥893.5b | CN¥15.5b | 15.9x | 21.9x | 0.4x |
| Tue, 10 Oct 2023 | CN¥335.2b | CN¥897.9b | CN¥15.9b | 16.2x | 21x | 0.4x |
| Thu, 07 Sep 2023 | CN¥322.8b | CN¥897.9b | CN¥15.9b | 15.9x | 20.2x | 0.4x |
| Sat, 05 Aug 2023 | CN¥342.8b | CN¥869.7b | CN¥17.2b | 14.4x | 19.9x | 0.4x |
| Mon, 03 Jul 2023 | CN¥363.3b | CN¥863.1b | CN¥17.1b | 15x | 21.2x | 0.4x |
| Wed, 31 May 2023 | CN¥366.1b | CN¥863.1b | CN¥17.1b | 15.2x | 21.4x | 0.4x |
| Fri, 28 Apr 2023 | CN¥377.8b | CN¥845.9b | CN¥19.7b | 17.4x | 19.2x | 0.4x |
| Sun, 26 Mar 2023 | CN¥347.3b | CN¥821.5b | CN¥18.7b | 15.5x | 18.6x | 0.4x |
| Tue, 21 Feb 2023 | CN¥351.0b | CN¥821.4b | CN¥18.2b | 15.4x | 19.3x | 0.4x |
| Thu, 19 Jan 2023 | CN¥337.0b | CN¥821.4b | CN¥18.2b | 14.4x | 18.5x | 0.4x |
| Sat, 17 Dec 2022 | CN¥353.7b | CN¥821.1b | CN¥18.2b | 18.4x | 19.4x | 0.4x |
| Mon, 14 Nov 2022 | CN¥325.5b | CN¥821.1b | CN¥18.2b | 18.2x | 17.9x | 0.4x |
| Wed, 12 Oct 2022 | CN¥267.8b | CN¥764.7b | CN¥16.8b | 14.6x | 15.9x | 0.4x |
| Fri, 09 Sep 2022 | CN¥287.1b | CN¥764.7b | CN¥16.8b | 17.8x | 17.1x | 0.4x |
| Sun, 07 Aug 2022 | CN¥293.4b | CN¥759.0b | CN¥16.1b | 21.6x | 18.2x | 0.4x |
| Tue, 05 Jul 2022 | CN¥329.5b | CN¥766.9b | CN¥17.6b | 16x | 18.7x | 0.4x |
| Thu, 02 Jun 2022 | CN¥301.7b | CN¥766.9b | CN¥17.6b | 15.5x | 17.2x | 0.4x |
| Sat, 30 Apr 2022 | CN¥292.3b | CN¥764.6b | CN¥18.0b | 12.5x | 16.2x | 0.4x |
| Mon, 28 Mar 2022 | CN¥331.4b | CN¥753.3b | CN¥19.3b | 16.5x | 17.2x | 0.4x |
| Wed, 23 Feb 2022 | CN¥297.7b | CN¥750.9b | CN¥19.7b | 14.8x | 15.1x | 0.4x |
Price to Earnings Ratio
15.1x
Current Industry PE
- Investors are relatively neutral on the Chinese Healthcare Distributors industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 18.8x.
- The industry is trading close to its 3-year average PS ratio of 0.37x.
Past Earnings Growth
- The earnings for companies in the Healthcare Distributors industry have declined 5.8% per year over the last three years.
- Meanwhile revenues for these companies have grown 6.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Chinese Healthcare Distributors compare with similar industries?
| CN Market | 1.46% | |
| Healthcare | 2.76% | |
| Healthcare Services | 4.35% | |
| Healthcare Distributors | 1.14% | |
| Healthcare Services | 17.28% | |
| Healthcare Facilities | 4.20% | |
| Managed Healthcare | 0% | 0 |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 000503 China Reform Health Management and Services Group | CN¥12.52 | 8.9% +CN¥1.0b | 35.2% | PS33.3x | |
| 600998 Jointown Pharmaceutical Group | CN¥5.12 | 2.4% +CN¥589.4m | -19.1% | PE12.3x | |
| 301015 Qingdao Baheal Medical | CN¥24.95 | 4.7% +CN¥588.7m | -20.3% | PE18.7x | |
| 301060 Shanghai Labway Clinical Laboratory | CN¥11.20 | 14.9% +CN¥578.4m | 17.9% | PS2.6x | |
| 301370 GKHT Medical Technology | CN¥12.00 | 9.6% +CN¥490.3m | -2.4% | PE34.5x |
